Alvotech, Kashiv Biosciences, and Advanz Pharma Announce Positive Results for AVT23, a Proposed Biosimilar to Xolair®
25/6 10:10
Alvotech, Kashiv, and Advanz Pharma report positive results for their biosimilar AVT23 compared to Xolair in clinical study....